CD274 and thyroid tumor: More than the exciting and robust immune infiltration that occurs when BRAFi and anti-PD-L1 work synergistically; it is obvious from the IHC results of our control group that aggressive thyroid tumors potentially grow without propagating anti tumor immune response.